How Single-Use Pumps are making Biopharmaceuticals Manufacturing Efficient?

Over the years, with constant drug developments, their manufacturing is increasingly transforming and becoming more based on Biologics, which, after all, represent several opportunities for developing new & more effective drugs & treatments for several lethal & incurable diseases. Yet, what gets the most attention is the challenges associated with the manufacturing procedures of these drugs and the assurance to perform the operations in the most sterile environment & time-sensitive situations.

To meet such needs in this highly competitive industry, several biopharmaceutical manufacturers are actively focusing on developing drugs with more flexibility, greener production lines, fast changeover, & minimal contamination risks. As a result, it has infused the need for single-use pumps in the biopharmaceutical industry globally. A recent research report published by MarkNtel Advisors has cited around 6.21% CAGR for the Global Single-Use Pumps in Biopharmaceutical Market during 2022-27.

Prime Forces behind the Rising Demand for Single-Use Pumps in Biopharmaceuticals

Single-use pumps are adopted extensively in the biopharmaceutical industry principally for processing equipment optimized for biological processes, i.e., playing a prominent role in manufacturing drugs in conditions where the target proteins require analysis and in situations when multiple variations are developed. The most prominent reason behind the rising demand for single-use pumps is their capability to allow multiple trials while developing drugs without any extra time required for cleaning & authenticating drugs.

Another factor backing the substantial rise in demand & utilization of these pumps includes the faster execution of subsequent trials, even when a particular protein is inaccurate, and re-run the same by disposing of the entire line & substituting it with a new one. It, in turn, enables biopharmaceutical companies to attain maximum production.

On the other hand, conventional mechanisms that utilize stainless-steel pumping & processing systems with permanent & multiple-use are highly time-consuming in terms of operation, cleaning, maintenance, & quality checking of pumps. Hence, to cut-short such time consumption, single-use pumps emerged as an ultimate solution for addressing all issues & bringing greater efficiency for biopharma manufacturers.

A Growing Shift from Conventional to Single-Use Pumps in Biopharmaceuticals

Rapid changes in age-specific healthcare & disease patterns are leading to significant advancements in current treatments and the advent of radically new concepts, including cell & gene therapies, which focus on regenerative medicines & disease degeneration. Massive investments by governments of different countries worldwide and the active participation of prominent companies in bringing greater efficiency in biopharmaceutical manufacturing through single-use pumps have helped address several challenges previously faced using conventional mechanisms. As a result, numerous biopharmaceutical companies are extensively adopting single-use pumps globally.

Besides, as industries are constantly witnessing developments and the advent of new technologies, the demand & inclination toward high-quality products is escalating swiftly, especially after the imposition of product quality & consumer safety standards by regulatory bodies toward improving safety. Nonetheless, the constant developments in the biopharmaceutical industry indicate the active participation of several companies & significant investments by governments in the sector, which, in turn, shall help the Global Single-Use Pumps in the Biopharmaceutical Market witness substantial growth in the coming years.